Global epidemiology of invasive meningococcal disease

Hdl Handle:
http://hdl.handle.net/10144/302226
Title:
Global epidemiology of invasive meningococcal disease
Authors:
Jafri, Rabab Z; Ali, Asad; Messonnier, Nancy E; Tevi-Benissan, Carol; Durrheim, David; Eskola, Juhani; Fermon, Florence; Klugman, Keith P; Ramsay, Mary; Sow, Samba; Zhujun, Shao; Bhutta, Zulfiqar A; Abramson, Jon
Journal:
Population Health Metrics
Abstract:
Neisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In countries with high endemic rates, the disease burden places an immense strain on the public health system. The worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and over time. This review summarizes the burden of IMD in different countries and identifies the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection. Available epidemiological data from the past 20 years in World Health Organization and European Centre for Disease Prevention and Control collections and published articles are included in this review, as well as direct communications with leading experts in the field. Countries were grouped into high-, moderate-, and low-incidence countries. The majority of countries in the high-incidence group are found in the African meningitis belt; many moderate-incidence countries are found in the European and African regions, and Australia, while low-incidence countries include many from Europe and the Americas. Priority countries for vaccine intervention are high- and moderate-incidence countries where vaccine-preventable serogroups predominate. Epidemiological data on burden of IMD are needed in countries where this is not known, particularly in South- East Asia and Eastern Mediterranean regions, so evidence-based decisions about the use of meningococcal vaccines can be made.
Publisher:
BioMed Central
Issue Date:
10-Sep-2013
URI:
http://hdl.handle.net/10144/302226
DOI:
10.1186/1478-7954-11-17
Additional Links:
http://www.pophealthmetrics.com/content/11/1/17
Submitted date:
2013-09-18
Language:
en
ISSN:
1478-7954
Appears in Collections:
Other Diseases

Full metadata record

DC FieldValue Language
dc.contributor.authorJafri, Rabab Zen_GB
dc.contributor.authorAli, Asaden_GB
dc.contributor.authorMessonnier, Nancy Een_GB
dc.contributor.authorTevi-Benissan, Carolen_GB
dc.contributor.authorDurrheim, Daviden_GB
dc.contributor.authorEskola, Juhanien_GB
dc.contributor.authorFermon, Florenceen_GB
dc.contributor.authorKlugman, Keith Pen_GB
dc.contributor.authorRamsay, Maryen_GB
dc.contributor.authorSow, Sambaen_GB
dc.contributor.authorZhujun, Shaoen_GB
dc.contributor.authorBhutta, Zulfiqar Aen_GB
dc.contributor.authorAbramson, Jonen_GB
dc.date.accessioned2013-09-24T20:49:44Z-
dc.date.available2013-09-24T20:49:44Z-
dc.date.issued2013-09-10-
dc.date.submitted2013-09-18-
dc.identifier.citationGlobal epidemiology of invasive meningococcal disease 2013, 11 (1):17 Population Health Metricsen_GB
dc.identifier.issn1478-7954-
dc.identifier.doi10.1186/1478-7954-11-17-
dc.identifier.urihttp://hdl.handle.net/10144/302226-
dc.description.abstractNeisseria meningitidis is one of the leading causes of bacterial meningitis globally and can also cause sepsis, pneumonia, and other manifestations. In countries with high endemic rates, the disease burden places an immense strain on the public health system. The worldwide epidemiology of invasive meningococcal disease (IMD) varies markedly by region and over time. This review summarizes the burden of IMD in different countries and identifies the highest-incidence countries where routine preventive programs against Neisseria meningitidis would be most beneficial in providing protection. Available epidemiological data from the past 20 years in World Health Organization and European Centre for Disease Prevention and Control collections and published articles are included in this review, as well as direct communications with leading experts in the field. Countries were grouped into high-, moderate-, and low-incidence countries. The majority of countries in the high-incidence group are found in the African meningitis belt; many moderate-incidence countries are found in the European and African regions, and Australia, while low-incidence countries include many from Europe and the Americas. Priority countries for vaccine intervention are high- and moderate-incidence countries where vaccine-preventable serogroups predominate. Epidemiological data on burden of IMD are needed in countries where this is not known, particularly in South- East Asia and Eastern Mediterranean regions, so evidence-based decisions about the use of meningococcal vaccines can be made.en_GB
dc.language.isoenen
dc.publisherBioMed Centralen_GB
dc.relation.urlhttp://www.pophealthmetrics.com/content/11/1/17en_GB
dc.rightsArchived with thanks to Population Health Metricsen_GB
dc.subjectMeningitisen_GB
dc.titleGlobal epidemiology of invasive meningococcal diseaseen
dc.identifier.journalPopulation Health Metricsen_GB
All Items in MSF are protected by copyright, with all rights reserved, unless otherwise indicated.